Comprehensive Blood and Cancer Center is excited to announce a significant advancement in our commitment to providing the highest standard of care for our patients. We have deployed the state-of-the-art Atellica advanced chemistry instruments, developed by Siemens, as part of our ongoing efforts to stay at the forefront of medical technology.
By embracing this groundbreaking laboratory technology, we are enhancing our service capabilities for both patients and providers. The implementation of Atellica enables us to achieve improved and faster results, empowering our health care team to deliver even more efficient and accurate diagnoses.
We take immense pride in being a trailblazer in the medical field. With the Atellica advanced chemistry instruments, we have established ourselves as a leader in the industry, offering the best chemistry equipment in town, surpassing even the standards set by many hospitals.
This groundbreaking technology opens new doors of opportunity for our dedicated team of healthcare professionals. It allows us to further elevate our patient-centered approach, ensuring the highest level of precision, reliability, and speed in diagnostic testing. With improved results, we can make timely and informed treatment decisions, paving the way for more effective cancer care.
• Complete Blood Count (CBC)
• Tumor Marker Tests
• Coagulation Testing
• Special Chemistries
• Bone Marrow
• Genomic Testing
• Genetic Testing
• Flow Cytometry
CBCC is accredited by the American College of Radiology (ACR) – the gold standard of medical imaging.
The ACR has a rigorous set of independent standards for patient safety and top quality care, with only 10% of the nation's radiation oncology centers having successfully passed the evaluation. We are very proud to have received this prestigious ACR Accreditation.